Dianthus Therapeutics, Inc. - Common Stock (DNTH)

$24.93 0.00 (0.00%)
16:00 EDT DNTH Stock Quote Delayed 30 Minutes

DNTH Stock Earnings: Dianthus Therapeutics Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings
DNTH stock results show that Dianthus Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

DNTH Stock Earnings: Dianthus Therapeutics Beats EPS, Beats Revenue for Q4 2023

DNTH Stock Earnings: Dianthus Therapeutics Reported Results for Q3 2023

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.)
Day's Range -
52-Week Range $6.58 - $33.77
Dividend & Yield N/A (N/A)